OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
OrthoPediatrics Corp. (NASDAQ: KIDS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $42.00 price target on the stock.
OrthoPediatrics Corp. Achieves Record Preliminary Unaudited Revenue for Full Year 2024 and Issues 2025 Financial Guidance
OrthoPediatrics Corp. Announces Expansion of Specialty Bracing Division